May 15, 2012· Consumer Healthcare Products Association (CHPA) - Comment· FDA-2012-N-0171-0095
Please see the attached comments to Docket No. FDA-2012-N-0171, "Using innovative technologies and other conditions of safe use to expand which drug products can be considered nonprescription." These comments supplement our March 22, 2012, presentation at FDA's public meeting on the subject.